Replies to post #437399 on Anavex Life Sciences Corp (AVXL)

[crescentmotor]

Have you gotten any feedback from attendees or others on what kind of data [SAVA CTAD oral presentation] was revealed?

Yes--I was a little surprised that there were no updates since this was an oral presentation rather than a poster. I do expect a PR soon, perhaps next week, announcing the completion of patient enrollment in the second ongoing Phase III trial (REFOCUS). On another note, CUNY released a PR today staying further action regarding its investigative committee's report on Dr. Wang. In other words, it is kicking this embarrassing matter down the road. It's actually pretty irrelevant at this point except for the continuing FUD.